QMA

Guardant Health, Inc. (GH) — QMA analysis

Sector: Healthcare · Market cap: $13.6B · Price: $169,08 · Data as of 2026-10-23

51
/100
C
Composite grade
Higher score than 73% of 22,734 tracked stocks

A composite score of 51/100 places Guardant Health, Inc. in the neutral band, higher score than 73% of 22,734 tracked stocks. The highest-scoring layer is Relative strength; the lowest is Insider activity.

Analytical score, not investment advice. No score is an instruction or a guarantee. Past performance ≠ future results.

What 6 data layers say about GH

The composite fuses insiders, congressional trades, institutional 13F positions, fundamentals, momentum, seasonality and more into a single number.

LayerScore
Fundamental value (FVS)54/100
Technical trend (TSS)52/100
Relative strength (RS)81/100
Momentum (USS)57/100
Insider activity (IAS)10/100
Off-exchange trading (FINRA) / large flows (WHS)64/100

What does the QMA model currently show for Guardant Health, Inc.?

The composite score is a research starting point, not an instruction. What matters is layer confluence — whether the layers point in the same direction.

For GH the layers diverge — some score high (Relative strength), others low (Insider activity). The divergence is itself information: the model does not give a clear-cut picture. The score is an input into your own research, not a recommendation.

GH insider & smart money activity

Over the recent period we record 7 reported insider purchases and 85 sales for GH: predominance of reported sales (by dollar value). A description of the data layer, not an instruction.

GH seasonality

The historically strong window for GH was June 1–28 with a hit rate of 88% and an average move of 8.8% (9 years of history).

Historical data does not guarantee future results.

How GH compares

Similar stocks from the same sector:

Frequently asked questions

What is the composite score for GH stock?

51/100 (C) — Data as of 2026-10-23.

Are insiders buying GH stock?

Over the recent period, reported: purchases 7, sales 85 (purchases $6.35M, sales $46.7M). Insider activity: predominance of reported sales (by dollar value) — a description of reported data, not a trade instruction.

Where can I see live GH data?

Live GH data and the full screener are part of full access. Registration is free with no card — trial full access, then the free plan with a delayed data sample.

Free registration, no card — trial full access, then the free plan

Open GH detail →

Data from SEC and public markets. QMA is an analytical tool, not a registered investment advisor. No content on this page is investment advice or an instruction to buy or sell. Past performance does not guarantee future results.

⚠️ Important Notice: QMA is an analytical and educational tool, not investment advice. Scores, detections and ratings are descriptive, not buy/sell instructions. QMA is not a registered investment advisor (SEC / FINRA / MiFID II / ČNB). Consult a licensed financial advisor before any investment. Past performance does not guarantee future results; all investments carry the risk of capital loss.

Operator: Jaroslav Vojtášek · IČO: 48783447 · Place of business: U Jízdárny 577, 747 64 Velká Polom, Czech Republic · Register: Sole trader registered in the Czech Trade Licensing Register · E-mail: [email protected]